Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CASPOFUNGIN vs CEDIRANIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CASPOFUNGIN vs CEDIRANIB: Safety Overview

Metric CASPOFUNGIN CEDIRANIB
Total FAERS Reports 3,814 130
Deaths Reported 1,419 27
Death Rate 37.2% 20.8%
Hospitalizations 1,638 71
Average Patient Age 47.5 yrs 61.2 yrs
% Female Patients 42.8% 62.3%
FDA Approval Date Dec 30, 2016 N/A
Manufacturer Sandoz Inc N/A
Route INTRAVENOUS N/A
Marketing Status Discontinued N/A